Found: 4
Select item for more details and to access through your institution.
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 2, p. 293, doi. 10.1111/bjh.13199
- By:
- Publication type:
- Article
Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by <sup>90</sup>Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0012-3
- By:
- Publication type:
- Article
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization
- Published in:
- Transfusion, 2010, v. 50, n. 11, p. 2432, doi. 10.1111/j.1537-2995.2010.02723.x
- By:
- Publication type:
- Article
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 213, doi. 10.1002/ajh.22214
- By:
- Publication type:
- Article